文献速递肝病消化道肿瘤与早癌

代谢功能障碍相关脂肪性肝病和/或酒精摄入的肝癌风险:一项全国性研究

Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study.
PubMed 文献 · Am J Gastroenterol · 2024-06-27

该研究基于韩国2009至2010年全国健康体检的40-79岁人群,按非MASLD、MASLD、MetALD和ALD分类,随访中位13.3年。与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。

要点

  • 与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。
  • 老年和非肝硬化亚组更易受MASLD和/或酒精摄入对肝细胞癌风险的不利影响。
  • 在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。

核心结论

  • 与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。
  • 为有效一级预防肝细胞癌,需采取综合措施改善代谢功能障碍和酒精摄入习惯。

研究设计与样本

  • 纳入2009至2010年韩国全国健康体检的40-79岁参与者,共6,412,209人。
  • 按非MASLD、MASLD、MetALD和ALD分类,主要结局为肝细胞癌发生率,采用多变量Cox比例风险模型估计风险。

主要发现

  • 非MASLD、MASLD、MetALD和ALD的比例分别为59.5%、32.4%、4.8%和3.4%。
  • 中位随访13.3年期间,27,118人新发肝细胞癌。
  • 与非MASLD相比,MASLD的aHR为1.66(95%CI 1.62-1.71),MetALD的aHR为2.17(95%CI 2.08-2.27),ALD的aHR为2.34(95%CI 2.24-2.45)。
  • 老年和非肝硬化亚组更易受MASLD和/或酒精摄入对肝细胞癌风险的不利影响。
  • 在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。

关键数值与推荐

  • MetALD定义为每周酒精摄入男性210-420 g、女性140-350 g。
  • ALD定义为过量酒精摄入,每周酒精男性≥420 g或女性≥350 g。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: New terminologies of metabolic dysfunction-associated steatotic liver disease (MASLD) have been developed. We assessed hepatocellular carcinoma (HCC) risk across MASLD and/or alcohol intake. METHODS: We included participants aged 40-79 years receiving a national health checkup from 2009 to 2010 in the Republic of Korea, classified as follows: non-MASLD, MASLD, MASLD with increased alcohol intake (MetALD; weekly alcohol 210-420 g for male and 140-350 g for female individuals), and alcohol-associated liver disease (ALD; excessive alcohol intake with weekly alcohol ≥420 g for male or ≥350 g for female individuals). The primary outcome was HCC incidence. HCC risk was estimated using multivariable Cox proportional hazard models. RESULTS: Among 6,412,209 participants, proportions of non-MASLD, MASLD, MetALD, and ALD cases were 59.5%, 32.4%, 4.8%, and 3.4%, respectively. During follow-up (median 13.3 years), 27,118 had newly developed HCC. Compared with non-MASLD, the HCC risk increased from MASLD (adjusted hazard ratio [aHR] 1.66, 95% confidence interval [CI] 1.62-1.71) and MetALD (aHR 2.17, 95% CI 2.08-2.27) to ALD (aHR 2.34, 95% CI 2.24-2.45) in a stepwise manner. Furthermore, the older and non-cirrhosis subgroups were more vulnerable to detrimental effects of MASLD and/or alcohol intake, concerning HCC risk. Among the older, female, and cirrhosis subgroups, MetALD poses similar HCC risks as ALD. DISCUSSION: HCC risk increased from MASLD and MetALD to ALD in a stepwise manner, compared with non-MASLD. For an effective primary prevention of HCC, a comprehensive approach should be required to modify both metabolic dysfunction and alcohol intake habit.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Yun B, Park H, Ahn SH, et al. Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study. Am J Gastroenterol. 2024. PMID: 38934496. doi:10.14309/ajg.0000000000002920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。